HOLX | Hologic, Inc. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	77.50 - 78.98
52 Week Range	67.59 - 84.67
Beta	0.94
Implied Volatility	25.86%
IV Rank	39.55%
Day's Volume	698,554
Average Volume	1,488,722
Shares Outstanding	226,941,000
Market Cap	17,767,210,890
Sector	Healthcare
Industry	Medical - Instruments & Supplies
IPO Date	1990-03-01

Valuation
Profitability
Growth
Health
P/E Ratio	23.58
Forward P/E Ratio	14.95
EPS	3.32
1YR Price Target	85.00
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	6,990
Country	USA
Website	HOLX

Hologic manufactures proprietary products for the healthcare needs of women. The company operates in five segments: diagnostics (64% of total sales, boosted by pandemic), breast health (21% of sales, suppressed by pandemic), surgical (12%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (75%), followed by Europe (16%), Asia (6%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.

HOLX's peers: ZTEK, AZTA, BAX, BDX, COO, HAE, ICUI, NVST, WST, TFX, ALC, RMD, MMSI, ANGO, ATR, ISRG, LH, LMAT, OSUR, RGEN, STAA, WRBY, XRAY, BLCO

*Chart delayed

Analyzing fundamentals for HOLX we got that it has strong fundamentals where Valuation is considered to be undervalued, Profitability is wealthy, Growth is exceptionally good and Health is confidently strong. For more detailed analysis please see HOLX Fundamentals page.

Watching at HOLX technicals we can see that long-term trend is bullish, while middle-term trend is bearish, as well as bearish short-term trend. More technicals details can be found on HOLX Technicals page.